Filter CategoriesAllPress & MediaBlog Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202 Senti Bio delivers exciting initial Phase 1 data for SENTI-202,... December 2, 2024 Press & Media NSG BioLabs and Merck Collaborates to Support Biotech Start-ups to Advance Research & Innovations The collaboration focuses on offering guidance, mentorship, and access to... August 15, 2024 Press & Media NSG BioLabs and Eppendorf Group partner to support biotech companies in Singapore NSG BioLabs and Eppendorf Group partner to support biotech companies... June 13, 2024 Press & Media NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with Enter... Fresh funding will be used to augment NSG BioLabs' infrastructure,... May 7, 2024 Press & Media SG BioLabs bags US$14.5 million funding; inks tie-ups with Merck, EnterpriseSG The funds will go towards new facilities and co-working sites,... May 7, 2024 Press & Media VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instea... VerImmune wants to offer new treatment possibilities for patients facing... April 10, 2024 Press & Media